DUBLIN–(BUSINESS WIRE)–The “International Glycomics/Glycobiology Market by Product (Enzymes (Glycosidases, Transferases), Devices (Mass Spectrometry, Chromatography, Arrays), Kits, Carbohydrates, Reagents), Utility (Drug Discovery, Diagnostics), Finish-user, and Area – Forecast to 2027” report has been added to ResearchAndMarkets.com’s providing.
The worldwide glycomics/glycobiology market is projected to succeed in USD 3.7 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 15.5% throughout the forecast interval. The expansion of the market is projected to be pushed by elements reminiscent of rising variety of collaboration and partnership by outstanding gamers out there for improved glycan evaluation, rising use of glycans as biomarker, and technological development.
The enzyme section grabbed the best share of the glycomics/glycobiology market in 2022
Based mostly on product, the glycomics/glycobiology market is segmented into enzymes, kits, devices, carbohydrates and reagents & chemical compounds. In 2022, the best share of the market is held by enzyme section. That is owing to the consumable nature of enzymes and huge utility in R&D actions.
The drug discovery & growth section accounts for the biggest share of the appliance section in glycomics/glycobiology market
In 2021, the drug discovery & growth section accounted for the biggest share of the market. The most important share of this section is as a result of rising utility of glycomics in drug discovery and growth and rising R&D funding by pharmaceutical & biotechnology.
North America: Accounted for the biggest share within the glycomics/glycobiology market
The North America is estimated to be the fastest-growing section of the market, owing to the rising presence of pharmaceutical and biotechnology firms, improved healthcare infrastructure and extra rising investments by firms in glycobiology analysis. On this area, US reviews the quickest development of the glycomics/glycobiology market.
- Emergence of Glycans as Biomarkers
- Technological Developments in Glycan Evaluation
- Growing R&D Expenditure and Funding
- Collaborations and Partnerships
- Growing Variety of Most cancers Instances Worldwide
- Excessive Price of Glycobiology Merchandise and Instruments
- Glycomics Purposes in Precision Drugs
- Lack of Expert Workforce
Key Matters Lined:
2 Analysis Methodology
3 Govt Abstract
4 Premium Insights
5 Market Overview
6 Glycomics/Glycobiology Market, by Product
7 Glycomics/Glycobiology Market, by Utility
8 Glycomics/Glycobiology Market, by Finish-user
9 Glycomics/Glycobiology Market, by Area
10 Aggressive Panorama
11 Firm Profiles
Firms Talked about
- Agilent Applied sciences
- Asparia Glycomics
- Bruker Company
- CD BioGlyco
- Chemily Glycoscience
- Danaher Company
- Glyxera GmbH
- IEC S.p.A.
- Kode Biotech Restricted
- Lectenz Bio
- Merck KGaA
- New England Biolabs
- Promega Company
- Raybiotech Life
- Shimadzu Company
- Sumitomo Bakelite
- Takara Bio
- Thermo Fisher Scientific
- Waters Company
- Z Biotech, LLC
For extra details about this report go to https://www.researchandmarkets.com/r/jsurml